Fig. 1
From: MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells
The expressions of LIMK1 and miR-106a in OSCC tissues and cell lines. a Quantitative RT-PCR analysis of LIMK1 and LIMK2 expressions in OSCC tissues (n = 20) and adjacent normal tissues (n = 10). Transcript levels were normalized to GAPDH expression. b Relative LIMK1 expression analyzed via quantitative RT-PCR in three OSCC cell lines normalized to GAPDH (n = 6). c Quantitative RT-PCR analysis of miR-106a level in OSCC tissues and adjacent normal tissues. Transcript levels were normalized to U6. d Relative miR-106a level analyzed via quantitative RT-PCR in three OSCC cell lines normalized to U6 (n = 6). e Pearson’s correlation analysis of the relative expression levels of miR-106a and the relative LIMK1 mRNA levels in OSCC tissues. All data are presented as means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 vs. normal tissues or NHOK